AQST Dividend History & Analysis | Yield
AQST has a dividend yield of and paid per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| SYMBOL | MARKET CAP USD | YIELD TTM | YIELD ON COST 5y |
|---|---|---|---|
| SAN PA Sanofi |
94,932 M | 5.54% | 6.18% |
| BMY NYSE Bristol-Myers Squibb |
120,765 M | 4.38% | 5.44% |
| TAK NYSE Takeda Pharmaceutical |
59,163 M | 3.83% | 6.23% |
| NVS NYSE Novartis |
273,228 M | 3.06% | 6.99% |
| GSK NYSE GlaxoSmithKline |
92,703 M | 3.53% | 5.75% |
| NOVN SW Novartis |
269,196 M | 2.99% | 6.18% |
| VTRS NASDAQ Viatris |
20,261 M | 3.50% | 4.39% |
| MRK NYSE Merck |
351,276 M | 2.89% | 5.14% |
| HLUN-B CO H Lundbeck |
6,973 M | 3.08% | 3.67% |
| ROP SW Roche Holding |
342,983 M | 3.05% | 3.18% |
| SYMBOL | MARKET CAP USD | GROWTH RATE | CONSISTENCY |
|---|---|---|---|
| HLUN-B CO H Lundbeck |
6,973 M | 26.64% | 100.0% |
| SECT-B ST Sectra (publ) |
5,989 M | 22.28% | 99.2% |
| FAGR BR Fagron |
1,854 M | 18.76% | 100.0% |
| LLY NYSE Eli Lilly |
1,042,981 M | 15.24% | 100.0% |
| NVS NYSE Novartis |
273,228 M | 8.79% | 100.0% |
| MRK NYSE Merck |
351,276 M | 5.34% | 100.0% |
| SAN PA Sanofi |
94,932 M | 5.39% | 100.0% |
| RPRX NASDAQ Royalty Pharma |
33,387 M | 5.31% | 100.0% |
| IPN PA Ipsen |
13,164 M | 7.55% | 98.0% |
| JNJ NYSE Johnson & Johnson |
599,125 M | 4.72% | 100.0% |
AQST Dividend History
Dividend Monthly Return EX date, 0 years of data
Average monthly dividend return by ex-dividend date. The score below shows reliability based on how consistently dividends were paid in that month.
AQST Dividend FAQ
As of October 2026, AQST's dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 4.61.
As of October 2026 AQST does not pay a dividend.
Over the last 12 months, AQST has issued dividend payments.
Based on historical data, the forecasted dividends per share for AQST for the next payments are between 0 (+0.0%) and 0 (+0.0%). This suggests the dividend will remain relatively stable. The expected Yield for the next 12 months is about -%.
The next Ex-Dividend date for Aquestive Therapeutics (AQST) is currently unknown.
The next Ex-Dividend date for Aquestive Therapeutics (AQST) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.
AQST's average dividend growth rate over the past 5 years is -% per year.
AQST's 5-Year Yield on Cost is -%. If you bought AQST's shares at 4.07 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.
AQST Payout Consistency is 0.0%. The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
AQST's % Dividend Yield is considered as unknown.
The Dividend Payout Ratio of AQST is unknown.
AQST's Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.
AQST Outstanding Shares Analysis
Key Metric Definitions
Annual dividend per share divided by current share price.
Percentage of earnings paid as dividends. Below 60% = safe, above 100% = unsustainable.
Percentage of Free Cash Flow paid as dividends. More reliable than Payout Ratio since it measures actual cash.
Compound annual growth rate of dividends over the last 5 years.
Reliability of dividend payments over lifetime. Penalizes cuts and pauses.
Your effective yield if you bought 5 years ago. Shows dividend growth impact over time.
Consecutive years of dividend payments. 25+ years = Dividend Aristocrat.
Proprietary score (0-100) combining yield, growth, safety and consistency.
Last update: 2026-10-06 02:37 UTC